Abdominal Wall Defect

Categories: Gastrointestinal diseases, Respiratory diseases

Aliases & Classifications for Abdominal Wall Defect

Summaries for Abdominal Wall Defect

Genetics Home Reference : 25 An abdominal wall defect is an opening in the abdomen through which various abdominal organs can protrude. This opening varies in size and can usually be diagnosed early in fetal development, typically between the tenth and fourteenth weeks of pregnancy. There are two main types of abdominal wall defects: omphalocele and gastroschisis. Omphalocele is an opening in the center of the abdominal wall where the umbilical cord meets the abdomen. Organs (typically the intestines, stomach, and liver) protrude through the opening into the umbilical cord and are covered by the same protective membrane that covers the umbilical cord. Gastroschisis is a defect in the abdominal wall, usually to the right of the umbilical cord, through which the large and small intestines protrude (although other organs may sometimes bulge out). There is no membrane covering the exposed organs in gastroschisis. Fetuses with omphalocele may grow slowly before birth (intrauterine growth retardation) and they may be born prematurely. Individuals with omphalocele frequently have multiple birth defects, such as a congenital heart defect. Additionally, underdevelopment of the lungs is often associated with omphalocele because the abdominal organs normally provide a framework for chest wall growth. When those organs are misplaced, the chest wall does not form properly, providing a smaller than normal space for the lungs to develop. As a result, many infants with omphalocele have respiratory insufficiency and may need to be supported with a machine to help them breathe (mechanical ventilation). Rarely, affected individuals who have breathing problems in infancy experience recurrent lung infections or asthma later in life. Affected infants often have gastrointestinal problems including a backflow of stomach acids into the esophagus (gastroesophageal reflux) and feeding difficulty; these problems can persist even after treatment of omphalocele. Large omphaloceles or those associated with multiple additional health problems are more often associated with fetal death than cases in which omphalocele occurs alone (isolated). Omphalocele is a feature of many genetic syndromes. Nearly half of individuals with omphalocele have a condition caused by an extra copy of one of the chromosomes in each of their cells (trisomy). Up to one-third of people born with omphalocele have a genetic condition called Beckwith-Wiedemann syndrome. Affected individuals may have additional signs and symptoms associated with these genetic conditions. Individuals who have gastroschisis rarely have other birth defects and seldom have chromosome abnormalities or a genetic condition. Most affected individuals experience intrauterine growth retardation and are small at birth; many affected infants are born prematurely. With gastroschisis, the protruding organs are not covered by a protective membrane and are susceptible to damage due to direct contact with amniotic fluid in the womb. Components of the amniotic fluid may trigger immune responses and inflammatory reactions against the intestines that can damage the tissue. Constriction around exposed organs at the abdominal wall opening late in fetal development may also contribute to organ injury. Intestinal damage causes impairment of the muscle contractions that move food through the digestive tract (peristalsis) in most children with gastroschisis. In these individuals, peristalsis usually improves in a few months and intestinal muscle contractions normalize. Rarely, children with gastroschisis have a narrowing or absence of a portion of intestine (intestinal atresia) or twisting of the intestine. After birth, these intestinal malformations can lead to problems with digestive function, further loss of intestinal tissue, and a condition called short bowel syndrome that occurs when areas of the small intestine are missing, causing dehydration and poor absorption of nutrients. Depending on the severity of the condition, intravenous feedings (parenteral nutrition) may be required. The health of an individual with gastroschisis depends largely on how damaged his or her intestine was before birth. When the abdominal wall defect is repaired and normal intestinal function is recovered, the vast majority of affected individuals have no health problems related to the repaired defect later in life.

MalaCards based summary : Abdominal Wall Defect, also known as gastroschisis, is related to shprintzen omphalocele syndrome and omphalocele-cleft palate syndrome, lethal. The drugs Bupivacaine and Ketorolac have been mentioned in the context of this disorder. Affiliated tissues include liver, heart and small intestine.

Wikipedia : 74 Abdominal wall defects are a type of congenital defect that allows the stomach, the intestines, or other... more...

Related Diseases for Abdominal Wall Defect

Diseases related to Abdominal Wall Defect via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 446)
# Related Disease Score Top Affiliating Genes
1 shprintzen omphalocele syndrome 12.7
2 omphalocele-cleft palate syndrome, lethal 12.7
3 omphalocele, diaphragmatic hernia, and radial ray defects 12.4
4 omphalocele, x-linked 12.3
5 shprintzen-goldberg craniosynostosis syndrome 12.2
6 diaphragmatic agenesis radial aplasia omphalocele 12.2
7 familial omphalocele syndrome with facial dysmorphism 12.2
8 hydrocephalus with associated malformations 11.9
9 oeis complex 11.8
10 beckwith-wiedemann syndrome 11.7
11 pagod syndrome 11.7
12 cloacal exstrophy 11.7
13 gastroschisis 11.7
14 omphalocele 11.6
15 otopalatodigital syndrome, type ii 11.6
16 boomerang dysplasia 11.6
17 donnai-barrow syndrome 11.6
18 paraomphalocele 11.5
19 constricting bands, congenital 11.5
20 omphalocele, autosomal 11.5
21 miller-dieker lissencephaly syndrome 11.4
22 acrocephalopolydactylous dysplasia 11.4
23 fibrochondrogenesis 11.4
24 schisis association 11.4
25 manitoba oculotrichoanal syndrome 11.4
26 gonadal dysgenesis, dysmorphic facies, retinal dystrophy, and myopathy 11.2
27 fryns microphthalmia syndrome 11.2
28 kagami-ogata syndrome 11.2
29 hyperthermia induced defects 11.2
30 hyperekplexia 11.2
31 hypertelorism, teebi type 11.1
32 3mc syndrome 3 11.1
33 3mc syndrome 1 11.1
34 3mc syndrome 2 11.1
35 robinow syndrome, autosomal recessive 2 11.1
36 froster-huch syndrome 11.1
37 ichthyosis follicularis atrichia photophobia syndrome 11.1
38 methimazole antenatal exposure 11.1
39 neural tube defects 10.3
40 exstrophy of bladder 10.3
41 peritonitis 10.3
42 colonic atresia 10.3
43 intestinal obstruction 10.2
44 macroglossia 10.2
45 prune belly syndrome 10.2
46 mercury poisoning 10.2
47 gastric dilatation 10.2
48 cryptorchidism, unilateral or bilateral 10.2
49 thoracoabdominal syndrome 10.2
50 inguinal hernia 10.2

Graphical network of the top 20 diseases related to Abdominal Wall Defect:

Diseases related to Abdominal Wall Defect

Symptoms & Phenotypes for Abdominal Wall Defect

Drugs & Therapeutics for Abdominal Wall Defect

Drugs for Abdominal Wall Defect (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 114)
# Name Status Phase Clinical Trials Cas Number PubChem Id
Bupivacaine Approved, Investigational Phase 4 38396-39-3, 2180-92-9 2474
Ketorolac Approved Phase 4 74103-06-3, 66635-83-4 3826
Glycerol Approved, Investigational Phase 4 56-81-5 753
Tocopherol Approved, Investigational Phase 4 1406-66-2, 54-28-4 14986
Sorbitol Approved Phase 4 50-70-4 5780
6 Coconut Approved Phase 4
Vitamin E Approved, Nutraceutical, Vet_approved Phase 4 59-02-9 14985
8 Tocotrienol Investigational Phase 4 6829-55-6
9 Anesthetics, Local Phase 4
10 Ketorolac Tromethamine Phase 4
11 Protective Agents Phase 4
12 Gastrointestinal Agents Phase 4
13 Liver Extracts Phase 4
14 Fat Emulsions, Intravenous Phase 4
15 Pharmaceutical Solutions Phase 4
16 Soybean oil, phospholipid emulsion Phase 4
17 Parenteral Nutrition Solutions Phase 4
18 Soy Bean Phase 4
19 Cathartics Phase 4
20 Tocopherols Phase 4
21 Tocotrienols Phase 4
22 Laxatives Phase 4
23 Olive Phase 4
leucovorin Approved Phase 3 58-05-9 6006 143
Dopamine Approved Phase 3 51-61-6, 62-31-7 681
Metoclopramide Approved, Investigational Phase 3 364-62-5 4168
Neostigmine Approved, Vet_approved Phase 3 59-99-4 4456
Folic acid Approved, Nutraceutical, Vet_approved Phase 3 59-30-3 6037
29 Micronutrients Phase 3
30 Vitamins Phase 3
31 Trace Elements Phase 3
32 Hematinics Phase 3
33 Vitamin B Complex Phase 3
34 Nutrients Phase 3
35 Vitamin B9 Phase 3
36 Folate Phase 3
37 Omega 3 Fatty Acid Phase 2, Phase 3
Bilirubin Phase 2, Phase 3 635-65-4, 69853-43-6 5280352 21252250
39 Antiemetics Phase 3
40 Dopamine D2 Receptor Antagonists Phase 3
41 Dopamine Antagonists Phase 3
42 Dopamine Agents Phase 3
43 Anesthetics Phase 3
44 Neurotransmitter Agents Phase 3
45 Autonomic Agents Phase 3
46 Neuromuscular Agents Phase 3
47 Neuromuscular Blocking Agents Phase 3
48 Cholinergic Agents Phase 3
49 Cholinesterase Inhibitors Phase 3
Acetaminophen Approved Phase 2 103-90-2 1983

Interventional clinical trials:

(show top 50) (show all 114)
# Name Status NCT ID Phase Drugs
1 Evaluation of the Safety and Efficacy of EXPAREL® When Infiltrated Into the Transversus Abdominis Plane (TAP) for Prolonged Postoperative Analgesia in Subjects Undergoing Unilateral Abdominal Hernia Repair Completed NCT01801124 Phase 4 EXPAREL
2 Liposomal Bupivacaine (Exparel) for Postoperative Pain Control for Open and Laparoscopic Abdominal Hernia Repair Completed NCT02128646 Phase 4 EXPAREL;Ketorolac
3 Results of Open Mesh Versus Suture Repair in Treatment of Abdominal Wall (Multicentric, Prospective, Randomised, Internet-based, Clinical Trial) Completed NCT01018524 Phase 4
4 A Randomized, Prospective, Double-blind, Multi-Center Study To Examine And Compare The Outcomes Associated With The Use Of Flex HD®, A Human Acellular Dermal Matrix, And Strattice™, A Porcine Acellular Dermal Matrix Allograft, When Used As A Reinforcing Material In The Repair Of Large Abdominal Wall Hernias By A Component Separation Technique Completed NCT01987700 Phase 4
5 Prospective Trial Comparing the Performance Profiles of Two Non-Cross-Linked Porcine Dermal Matrices in Abdominal Wall Reconstruction Recruiting NCT02228889 Phase 4
6 The Use of Gastrografin to Help Alleviate Bowel Obstruction Related to Poor Bowel Motility in Gastroschisis Patients. Recruiting NCT03334578 Phase 4 Gastrografin
7 Evaluation of Routine Administration of Glycerin Suppositories to Improve Bowel Function in Patients With Uncomplicated Gastroschisis Recruiting NCT03355326 Phase 4 Glycerin Suppository
8 A Multicenter, Prospective, Single-Blind, Randomized, Controlled Study of the Repair of Challenging Abdominal Wall Defects: Strattice(TM) TM in Abdominal Wall Repair Terminated NCT01083472 Phase 4
9 Low Dose Parenteral Fat for the Prevention of Parenteral Nutrition Associated Cholestasis in Neonates With Congenital/Acquired Gastrointestinal Disorders Terminated NCT01373918 Phase 4 Intralipid;Intralipid
10 Incidence and Severity of Parenteral Nutrition Associated Cholestasis in Neonates Subjected to Major Surgery, Using Two Mixed Intravenous Lipid Emulsions Terminated NCT02633384 Phase 4
11 Randomized Trial of AMNIOECHANGE in Gastroschisis Affected Foetuses Unknown status NCT00127946 Phase 3
12 Randomized Clinical Trial to Evaluate the Efficacy of High Dose of Folic Acid to Prevent the Occurrence of Congenital Malformations Unknown status NCT01244347 Phase 3 folic acid;folic acid
13 The Use of Probiotics in the Management of Necrotizing Enterocolitis in HIV-exposed Premature and Very-low Birth Weight Infants Completed NCT01868737 Phase 3
14 The North American Study for the Treatment of Refractory Ascites (NASTRA) Clinical Trial Completed NCT00006166 Phase 3
15 Fish Oil Lipid Emulsion for the Treatment of Parenteral-Nutrition-Associated Liver Disease in Infants Completed NCT02370251 Phase 2, Phase 3 Omegaven
16 The Use of Metoclopramide vs. Placebo in Infants With Gastroschisis. A Pilot Double Blind Randomized Controlled Trial Recruiting NCT02098915 Phase 3 intravenous metoclopramide
17 Evaluation of Sugammadex Vs. Neostigmine in the PACU for Abdominal Surgeries Not yet recruiting NCT04096144 Phase 3 Neuromuscular Blocking Agents
18 Abdominal Wall Closure After TRAM / DIEP Flap - Comparison of TIGR Mesh vs Polypropylene Mesh. Unknown status NCT01136603 Phase 2
19 The Buckypaper as a New Device in the Treatment of Some Solid Cancer and Hematopoietic System Tumors and as a New Fixing Device for Prosthetic Surgery. In Vivo Study on Effects of BP Implantation, Preliminary to Human Surgical Applications Unknown status NCT02328352 Phase 1, Phase 2
20 A Multi-Centre, Prospective Randomized Trial to Evaluate Routine Use of a Silastic Spring-Loaded Silo for Infants With Gastroschisis Completed NCT00539292 Phase 2
21 Compassionate Use of an Intravenous Fish Oil Lipid Emulsion (Omegaven®) for the Treatment of Intestinal Failure Associated Liver Disease in Children Completed NCT02328768 Phase 2 Omegaven
22 The Effect of Multimodal Pain Therapy After Hernia Repair Recruiting NCT03792295 Phase 2 acetominophen, ibuprofen, oxycodone;Oxycodone
23 Phase 2 Study of Oral Probiotics Reduce the Incidence and Severity of Necrotizing Enterocolitis for Very Low Birth Weight Infants -Multi-Center Randomized Control Trial Terminated NCT00540033 Phase 2
24 Phase 1-2 Trial of Glucagon-like Peptide 2 (GLP-2) in Infants and Children With Intestinal Failure Terminated NCT01573286 Phase 1, Phase 2 Glucagon-Like Peptide 2;Glucagon like peptide-2
25 An Open-label, Single-arm, Phase 1 Study Examining the Safety and Efficacy of Fibrin Sealant Plus Silver Microparticles to Prevent Incisional Hernias (HiP_1 Trial) Following Abdominal Surgery Not yet recruiting NCT02584153 Phase 1 Fibrin Sealant;Silver Microparticles
26 The Use of Elemental Formula in Neonates Post Small Bowel Resection: Improved Success to Wean From Total Parenteral Nutrition? Unknown status NCT01891279
27 Evaluation of Abdominal Tissue Oxygenation in Premature Infants Using Near Infrared Spectroscopy Unknown status NCT01855347
28 Evaluation of Feeding Intolerance in Premature Infants Using Near Infrared Spectroscopy Unknown status NCT02534090
29 Full-thickness Skin vs. Synthetic Mesh in the Repair of Large Incisional Hernia - a Prospective Randomized Controlled Study Unknown status NCT01413412
30 The Effect of Music Therapy On Infants Born With Gastroschisis Unknown status NCT01469208
31 Mesh Used Repairs in Emergency Abdominal Wall Hernias Unknown status NCT01578538
32 Study for the Evaluation of the Efficiency of a Device for the Diagnosis of an Internal Rectal Prolapse, a Pelvic Floor Ptosis and for the Determination of an Internal Hernia Into the Douglas Pouch Unknown status NCT00836680
33 A Prospective Randomized Study to Evaluate Two Different Surgical Methods for Treatment for Abdominal Wall Diastasis Unknown status NCT01586741
34 Abdominal CT Angiography of Mesenteric Vessels for Diagnosing Internal Herniation After Roux-en-Y Gastric Bypass Surgery Unknown status NCT03114761
35 Case-control Study of Mesh-infection After a Size Tailored Hernia Repair With C-Qur V-Patch Unknown status NCT01761708
36 PreOperative Steroid in Abdominal Wall Reconstruction: A Double-blinded Randomized Clinical Trial Unknown status NCT02594241 Methyl-Prednisolone;Physiological saline
37 Post-Operative Pain After Laparoscopic Ventral Hernia Repair, Impact of Mesh Impregnation With Bupivacaine Solution vs. Normal Saline Solution Unknown status NCT03035617 Bupivacaine
38 Probiotics Supplementation and Length of Hospital Stay in Neonates With Gastrointestinal Surgery Unknown status NCT03266315
39 Health Related Quality of Life of Patients With Abdominal Wall Defects Completed NCT03960320
40 A Multicenter, Prospective, Observational Evaluation of Repair of Infected or Contaminated Hernias (RICH) Using LTM Completed NCT00617357
41 Repair of Large Abdominal Hernia Defects By A Novel Biologic Mesh: A Prospective Multi-Center Observational Study Completed NCT00892333
42 Quality of Life Evaluations in Patients With Abdominal Wall Hernias Completed NCT01115400
43 Abdominal Hernia in Cirrhotic Patients: Surgery or Conservative Treatment? Completed NCT02787772
44 Clinical and Biological Outcomes of Human Milk and Formula Intake After Gastroschisis Repair Completed NCT02575846
45 Collagen Alterations in Patients With Abdominal Wall Hernias Completed NCT02734563
46 Intra-Abdominal Hypertension in Neonatal Intensive Care Patients Completed NCT00747552
47 Bedside Silo Versus Attempted Operative Closure for Gastroschisis Completed NCT01506531
48 A Randomized Controlled Trial Comparing Combination Therapy of Acetaminophen Plus Ibuprofen Versus Tylenol #3 for the Treatment of Pain After Outpatient Surgery Completed NCT00245375 Tylenol #3;Combination Tylenol and Ibuprofen
49 Probiotics in Infants With Gastroschisis Completed NCT01316510
50 Prospective Case-control Study on the Incidence of Incisional Hernias at 12 Months After Closure of Midline Laparotomies in Patients Treated for Abdominal Aortic Aneurysm Completed NCT02012270

Search NIH Clinical Center for Abdominal Wall Defect

Genetic Tests for Abdominal Wall Defect

Anatomical Context for Abdominal Wall Defect

MalaCards organs/tissues related to Abdominal Wall Defect:

Liver, Heart, Small Intestine, Lung, Colon, Skin, Kidney

Publications for Abdominal Wall Defect

Articles related to Abdominal Wall Defect:

(show top 50) (show all 3055)
# Title Authors PMID Year
Central line associated blood stream infections in gastroschisis patients: A nationwide database analysis of risks, outcomes, and disparities. 61
31708200 2020
Global surgery. 61
31784101 2020
ADHD Medication Use During Pregnancy and Risk for Selected Birth Defects: National Birth Defects Prevention Study, 1998-2011. 61
29519207 2020
Is Tapering Enteroplasty an Alternative to Resection of Dilated Bowel in Small Intestinal Atresia? 61
31541708 2020
Specific birth defects in pregnancies of women with diabetes: National Birth Defects Prevention Study, 1997-2011. 61
31454511 2020
Trisomy 18 in a First-Trimester Fetus with Thoraco-Abdominal Ectopia Cordis. 61
31215820 2020
Lessons learned from 227 biological meshes used for the surgical treatment of ventral abdominal defects. 61
30661179 2020
Mesh Fixation Using a Cyanoacrylate Applied as a Spray Improves Abdominal Wall Tissue Repair. 61
31557596 2020
[Autologous reconstructive surgery and intestinal rehabilitation in the management of short bowel syndrome]. 61
32037869 2020
Assessment of gastroschisis risk factors in Egypt. 61
31759649 2020
Inflammatory bowel disease and risk of birth defects in offspring. 61
31907519 2020
A comparison between placental and amniotic mesenchymal stem cells in transamniotic stem cell therapy for experimental gastroschisis. 61
31711742 2020
Vanishing Gastroschisis with a Favorable Outcome after a 3-Year Follow-Up: A Case Report and Literature Review. 61
31970004 2020
Mother's own milk dose is associated with decreased time from initiation of feedings to discharge and length of stay in infants with gastroschisis. 61
31992819 2020
Elective delivery at 34 weeks vs routine obstetric care in fetal gastroschisis: randomized controlled trial. 61
31503365 2020
Maternal occupational exposure to solvents and gastroschisis in offspring - National Birth Defects Prevention Study 1997-2011. 61
31949041 2020
Does overweight before pregnancy reduce the occurrence of gastroschisis?: the Japan Environment and Children's Study. 61
32000843 2020
Reducing Gastroschisis Mortality: A Quality Improvement Initiative at a Ugandan Pediatric Surgery Unit. 61
31965276 2020
Platelet-rich fibrin prevents postoperative intestinal adhesion. 61
31943765 2020
A systematic scoping review of clinical indications for induction of labour. 61
31995603 2020
Bronchogenic cyst presenting as content of omphalocele - A case report. 61
32031138 2020
Adherence to and outcomes of a University-Consortium gastroschisis pathway. 61
31704046 2020
Pediatric Cullen gangrene: Case report of postoperative pyoderma gangrenosum in a preterm infant with a complex gastrointestinal malformation. 61
31954341 2020
Predicting Morbidity and Mortality in Neonates Born With Gastroschisis. 61
31421366 2020
Prenatal detection of congenital anomalies and related factors in Argentina. 61
31900752 2020
Presence of congenital anomalies in three dog litters. 61
32003081 2020
Body wall defects and amniotic band syndrome in pig (Sus scrofa domesticus). 61
31513296 2020
Pregnancy outcomes of women with elevated second-trimester maternal serum alpha-fetoprotein. 61
32039804 2020
Burden of Neonatal Surgical Conditions in Northern Ghana. 61
31583459 2020
Value of routine ultrasound examination at 35-37 weeks' gestation in diagnosis of fetal abnormalities. 61
31595569 2020
Feeding problems and gastrointestinal diseases in Down syndrome. 61
31784293 2020
Transamniotic Stem Cell Therapy. 61
31302870 2020
Birth prevalence of congenital anomalies in the City of Buenos Aires, Argentina, according to socioeconomic level. 61
31900751 2020
Electrospun nanofiber mesh with fibroblast growth factor and stem cells for pelvic floor repair. 61
30888115 2020
Differences in attitudes to feeding post repair of Gastroschisis and development of a standardized feeding protocol. 61
31801489 2019
Feeding Tolerance, Intestinal Motility, and Superior Mesenteric Artery Blood Flow in Infants with Gastroschisis. 61
31851996 2019
Anterior abdominal wall defects managed at a tertiary maternal-fetal medicine service in New Zealand: What counselling advice can we offer parents? 61
30841012 2019
Gastroschisis in Finland 1993 to 2014-Increasing Prevalence, High Rates of Abortion, and Survival: A Population-Based Study. 61
31891948 2019
[Correlation between prenatal and postnatal observations in case of gastroschisis: Experience in a prenatal referral diagnosis center]. 61
31614232 2019
Umbilical reconstruction: different techniques, a single aim. 61
31910176 2019
Ventral hernia secondary to giant omphalocele in a child: combined approach of botulinum toxin and preoperative progressive pneumoperitoneum. 61
31858310 2019
Design of a new dual mesh with an absorbable nanofiber layer as a potential implant for abdominal hernia treatment. 61
31826319 2019
Biological Mesh Combined With Topical Negative Pressure Therapy in Complex Abdominal Wounds: A Short Series and a Review of the Literature. 61
31876512 2019
Gastro-intestinal function and quality of life are favorable in adolescent and adult gastroschisis patients. 61
31874371 2019
Using three-dimensional ultrasound in predicting complex gastroschisis: A longitudinal, prospective, multicenter cohort study. 61
31600419 2019
Change in prepregnancy body mass index and gastroschisis. 61
31928895 2019
Shared genomic segments in high-risk multigenerational pedigrees with gastroschisis. 61
31385443 2019
Defining the critical pediatric surgical workforce density for improving surgical outcomes: a global study. 61
31839371 2019
Donor mesenchymal stem cell kinetics after transamniotic stem cell therapy (TRASCET) in a rodent model of gastroschisis. 61
31813581 2019
Population-based birth defects data in the United States, 2012-2016: A focus on abdominal wall defects. 61
31642616 2019

Variations for Abdominal Wall Defect

ClinVar genetic disease variations for Abdominal Wall Defect:

6 ‎‎
# Gene Name Type Significance ClinVarId dbSNP ID GRCh37 Pos GRCh38 Pos
1 46;X;t(X;10)(p11.2;q24.3)Translocation Uncertain significance 267803

Expression for Abdominal Wall Defect

Search GEO for disease gene expression data for Abdominal Wall Defect.

Pathways for Abdominal Wall Defect

GO Terms for Abdominal Wall Defect

Sources for Abdominal Wall Defect

9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
31 HPO
32 ICD10
33 ICD10 via Orphanet
37 LifeMap
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
54 Novoseek
57 OMIM via Orphanet
61 PubMed
70 Tocris
72 UMLS via Orphanet
Loading form....